Dual defense: Opportunities and challenges of GLP-1 receptor agonists in reducing dementia risk in type 2 diabetes!
作者信息
Adnan Saman, Qureshi Muniza, Arif Sania, Fatima Kinza
机构信息
Department of health sciences, Ziauddin University, Karachi, Pakistan.
出版信息
Alzheimers Dement. 2025 May;21(5):e70336. doi: 10.1002/alz.70336.
Abstract
摘要
相似文献
1
Dual defense: Opportunities and challenges of GLP-1 receptor agonists in reducing dementia risk in type 2 diabetes!
Alzheimers Dement. 2025 May;21(5):e70336. doi: 10.1002/alz.70336.
2
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes.
Diabetes Metab. 2025 Mar;51(2):101623. doi: 10.1016/j.diabet.2025.101623. Epub 2025 Feb 12.
3
The Effects of Dual GLP-1/Glucagon Receptor Agonists with Different Receptor Selectivity in Mouse Models of Obesity and Nonalcoholic Steatohepatitis.
J Pharmacol Exp Ther. 2023 Mar;384(3):406-416. doi: 10.1124/jpet.122.001440. Epub 2022 Nov 23.
4
Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges.
J Endocrinol. 2024 Jul 22;262(3). doi: 10.1530/JOE-23-0404. Print 2024 Sep 1.
5
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
BMJ. 2023 Apr 6;381:e074068. doi: 10.1136/bmj-2022-074068.
6
GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes.
Diabetes Metab. 2023 Sep;49(5):101470. doi: 10.1016/j.diabet.2023.101470. Epub 2023 Aug 30.
7
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
BMJ. 2021 May 11;373:n1091. doi: 10.1136/bmj.n1091.
8
Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes.
Ann Endocrinol (Paris). 2023 Apr;84(2):316-321. doi: 10.1016/j.ando.2022.12.423. Epub 2023 Jan 10.
9
Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
Curr Ther Res Clin Exp. 2010 Aug;71(4):211-38. doi: 10.1016/j.curtheres.2010.08.003.
10
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
JAMA. 2025 Mar 25;333(12):1062-1073. doi: 10.1001/jama.2024.27402.
本文引用的文献
1
Glycated hemoglobin and body mass index as mediators of GLP-1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes.
Alzheimers Dement. 2025 Apr;21(4):e70161. doi: 10.1002/alz.70161.
2
Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis.
JAMA Neurol. 2025 May 1;82(5):450-460. doi: 10.1001/jamaneurol.2025.0360.
3
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.
Signal Transduct Target Ther. 2024 Sep 18;9(1):234. doi: 10.1038/s41392-024-01931-z.
4
Advancing dementia care in Pakistan: challenges and the way forward.
Front Dement. 2023 Sep 14;2:1241927. doi: 10.3389/frdem.2023.1241927. eCollection 2023.
5
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.
Diabetes Care. 2024 Nov 1;47(11):1873-1888. doi: 10.2337/dci24-0003.
6
Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.
Front Endocrinol (Lausanne). 2024 Feb 6;15:1330936. doi: 10.3389/fendo.2024.1330936. eCollection 2024.
7
Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers.
Alzheimers Dement (N Y). 2022 Feb 23;8(1):e12268. doi: 10.1002/trc2.12268. eCollection 2022.
8
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
9
Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.
J Diabetes Investig. 2013 Nov 27;4(6):640-50. doi: 10.1111/jdi.12087. Epub 2013 Apr 26.
Zotero 插件